Evidence map›Paper›PMID 35762769›Full record

ArticleMicrobiology spectrum2022

Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.

Margarita Trobos, Rininta Firdaus, Karin Svensson Malchau, Jonatan Tillander, Dimitrios Arnellos, Ola Rolfson, Peter Thomsen, Iñigo Lasa

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2023
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Staphylococcus aureus From Prosthetic Joint Infections and Blood Cultures Display the Same Genetic Background.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Beneficial perspective onFrontiers in immunology · 2025
    Review
  16. Dalbavancin-resistantJAC-antimicrobial resistance · 2024
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Margarita TrobosDepartment of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburggrid.8761.8, Gothenburg, Sweden.ORCID 0000-0002-9253-6771
Rininta FirdausDepartment of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Karin Svensson MalchauCenter for Antibiotic Resistance Research (CARe), University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Jonatan TillanderCenter for Antibiotic Resistance Research (CARe), University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Dimitrios Arnellos1928 Diagnostics, Gothenburg, Sweden.
Ola RolfsonDepartment of Orthopedics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburggrid.8761.8, Gothenburg, Sweden.
Peter ThomsenDepartment of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburggrid.8761.8, Gothenburg, Sweden.ORCID 0000-0003-3910-6665
Iñigo LasaLaboratory of Microbial Pathogenesis, Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.ORCID 0000-0002-6625-9221
Sahlgrenska University Hospital · SEUniversity of Gothenburg · SE1928 Diagnostics (Sweden) · SEUniversidad Publica de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The approach of sequencing or genotyping to characterize the pathogenic potential of staphylococci from orthopedic device-related infection (ODRI) has been applied in recent studies. These studies described the genomic carriage of virulence in clinical strains and compared it with those in commensal strains. Only a few studies have directly correlated genomic profiles to patient outcome and phenotypic virulence properties in periprosthetic joint infections (PJIs). We investigated the association between genomic variations and virulence-associated phenotypes (biofilm-forming ability and antimicrobial resistance) in 111 staphylococcal strains isolated from patients with PJI and the infection outcome (resolved/unresolved). The presence of a strong biofilm phenotype in Staphylococcus aureus and an antibiotic-resistant phenotype in Staphylococcus epidermidis were both associated with treatment failure of PJI. In S. epidermidis, multidrug resistance (MDR) and resistance to rifampicin were associated with unresolved infection. Sequence type 45 (ST45) and ST2 were particularly enriched in S. aureus and S. epidermidis, respectively. S. epidermidis ST2 caused the majority of relapses and was associated with MDR and strong biofilm production, whereas ST215 correlated with MDR and non/weak biofilm production. S. aureus

Indexed as

Prosthesis-Related InfectionsStaphylococcal InfectionsAnti-Bacterial AgentsBiofilmsGenomicsHumansRifampinStaphylococcus aureusStaphylococcus epidermidisAnti-Bacterial AgentsRifampinantibiotic resistancebiofilmpatient outcomeperiprosthetic joint infectionStaphylococcusvirulencewhole-genome sequencing

Identifiers

PMID35762769
PMCPMC9430453
OpenAlexW4283652996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.